Skip to content

Effects of Adhesive Tape on Abdominal Pain Control and Maternal Functionality After Cesarean Section

Effects of Compressive Taping on Abdominal Pain Controland Function in Postpartum Cesarean Section Woman: a randomized, single-blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-49mjdm7
Enrollment
60
Registered
2026-07-22
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal pain, cesarean section Post-partum period

Interventions

This is a two-arm, single-blind, randomized controlled clinical trial. Experimental group: 30 postpartum women will receive abdominal compression taping applied with moderate tension (between 30% and

Sponsors

Universidade Federal da Paraíba
Lead Sponsor
Universidade Federal da Paraíba
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Postpartum women within the first 24 hours after delivery; aged 18 to 45 years; abdominal pain intensity score of 3 or higher on the numerical pain scale; absence of dermatological conditions; absence of intellectual disability or perceptual impairments (such as perceptual deficits); absence of communication difficulties; willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Allergic skin problems; diabetic; develop postpartum complications (dehiscence, bleeding, infection, etc.); diagnosis or clinical suspicion of deep vein thrombosis

Design outcomes

Primary

MeasureTime frame
Assess abdominal pain using the numerical pain scale before the intervention and during the 7 consecutive days of treatment

Secondary

MeasureTime frame
Functionality will be assessed using questionnaires before the intervention and at the end of treatment. Treatment-related adverse effects and the global perception of improvement will also be evaluated via questionnaire, but only at the end of treatment

Countries

BR

Contacts

Public ContactLívia Silva

Universidade Federal da Paraíba

borbalivia01@gmail.com+55(81)99307-4830

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026